- 专利标题： Functionalized Heterocycles as Antiviral Agents
-
申请号： US18543151申请日： 2023-12-18
-
公开(公告)号： US20240262828A1公开(公告)日： 2024-08-08
- 发明人: Joseph D. PANARESE , Dexter DAVIS , Samuel BARTLETT , Katherine CHONG , Nathaniel Thomas KENTON , Yat Sun OR
- 申请人： Enanta Pharmaceuticals, Inc.
- 申请人地址： US MA Watertown
- 专利权人： Enanta Pharmaceuticals, Inc.
- 当前专利权人： Enanta Pharmaceuticals, Inc.
- 当前专利权人地址： US MA Watertown
- 主分类号： C07D471/14
- IPC分类号： C07D471/14 ; A61K45/06
摘要：
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, thereof:
which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
信息查询
